150 related articles for article (PubMed ID: 24717818)
1. Rapid hepatitis C testing among persons at increased risk for infection--Wisconsin, 2012-2013.
Stockman LJ; Guilfoye SM; Benoit AL; Vergeront JM; Davis JP;
MMWR Morb Mortal Wkly Rep; 2014 Apr; 63(14):309-11. PubMed ID: 24717818
[TBL] [Abstract][Full Text] [Related]
2. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.
Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D;
MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252
[TBL] [Abstract][Full Text] [Related]
3. Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):357-61. PubMed ID: 23657111
[TBL] [Abstract][Full Text] [Related]
4. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid.
Lee SR; Kardos KW; Schiff E; Berne CA; Mounzer K; Banks AT; Tatum HA; Friel TJ; Demicco MP; Lee WM; Eder SE; Monto A; Yearwood GD; Guillon GB; Kurtz LA; Fischl M; Unangst JL; Kriebel L; Feiss G; Roehler M
J Virol Methods; 2011 Mar; 172(1-2):27-31. PubMed ID: 21182871
[TBL] [Abstract][Full Text] [Related]
6. Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion.
Beld M; Penning M; van Putten M; van den Hoek A; Damen M; Klein MR; Goudsmit J
Blood; 1999 Aug; 94(4):1183-91. PubMed ID: 10438705
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
[TBL] [Abstract][Full Text] [Related]
8. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
[TBL] [Abstract][Full Text] [Related]
9. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
10. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
[TBL] [Abstract][Full Text] [Related]
11. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
12. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
Blackburn NA; Patel RC; Zibbell JE
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
[TBL] [Abstract][Full Text] [Related]
13. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
Hitzler WE; Runkel S
Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.
Armstrong GL; Wasley A; Simard EP; McQuillan GM; Kuhnert WL; Alter MJ
Ann Intern Med; 2006 May; 144(10):705-14. PubMed ID: 16702586
[TBL] [Abstract][Full Text] [Related]
15. Testing for HCV infection: an update of guidance for clinicians and laboratorians.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):362-5. PubMed ID: 23657112
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.
Boettiger DC; Law MG; Dore GJ; Guy R; Callander D; Donovan B; O'Connor CC; Fairley CK; Hellard M; Matthews G
BMC Infect Dis; 2017 Dec; 17(1):740. PubMed ID: 29191154
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
18. Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.
Jewett A; Smith BD; Garfein RS; Cuevas-Mota J; Teshale EH; Weinbaum CM
J Clin Virol; 2012 Jul; 54(3):213-7. PubMed ID: 22560051
[TBL] [Abstract][Full Text] [Related]
19. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
[TBL] [Abstract][Full Text] [Related]
20. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
